Intralesional and perilesional radiomics strategy based on different machine learning for the prediction of international society of urological pathology grade group in prostate cancer

基于不同机器学习方法的病灶内和病灶周围放射组学策略用于预测前列腺癌的国际泌尿病理学会分级组

阅读:1

Abstract

OBJECTIVE: To develop and evaluate a intralesional and perilesional radiomics strategy based on different machine learning model to differentiate International Society of Urological Pathology (ISUP) grade > 2 group and ISUP ≤ 2 prostate cancers (PCa). METHODS: 340 case of PCa patients confirmed by radical prostatectomy pathology were obtained from two hospitals. The patients were divided into training, internal validation, and external validation groups. Radiomic features were extracted from T2-weighted imaging, and four distinct radiomic feature models were constructed: intralesional, perilesional, combined tumoral and perilesional, and intralesional and perilesional image fusion. Four machine learning classifiers logistic regression (LR), random forest (RF), extra trees (ET), and multilayer perceptron (MLP) were employed for model training and evaluation to select the optimal model. The performance of each model was assessed by calculating the area under the ROC curve (AUC), accuracy, sensitivity, specificity, positive predictive value, negative predictive value, and F1 score. RESULTS: The AUCs for the RF classifier were higher than that of LR, ET, and MLP, and was selected as the final radiomic model. The nomogram model integrating perilesional, combined intralesional and perilesional, and intralesional and perilesional image fusion had an AUC of 0.929, 0.734, 0.743 for the training, internal, and external validation cohorts, respectively, which was higher than that of the individual intralesional, perilesional, combined intralesional and perilesional, and intralesional and perilesional image fusion models. CONCLUSIONS: The proposed nomogram established from perilesional, combined intralesional and perilesional, and intralesional and perilesional image fusion radiomic has the potential to predict the differentiation degree of ISUP PCa patients. CLINICAL TRIAL NUMBER: Not applicable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。